Obesity is falling for the first time as Ozempic and weight loss drugs riseByBruce GilPublishedOctober 4, 2024
Ozempic for all, Zepbound is back, and the top CEO pay: Pharma news roundupByBruce GilPublishedOctober 4, 2024
A mayor promises Ozempic for all and says there 'will be no more fat people' in his cityByBruce GilPublishedOctober 3, 2024
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellersByBruce GilUpdatedOctober 3, 2024
Oura just launched its latest smart ring. Apple and Samsung are coming for itByBruce GilPublishedOctober 3, 2024
Which streaming services lead in Latino representation? The best and worst platforms of 2024ByBruce GilPublishedOctober 3, 2024
A cable company is throwing in free streaming to keep customers from cutting the cordByBruce GilUpdatedOctober 2, 2024
Uber says a couple in a major crash can't sue because their daughter ordered UberEatsByBruce GilPublishedOctober 2, 2024
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right nowByBruce GilPublishedOctober 2, 2024
Drugs like Ozempic are now more popular than insulin for treating diabetesByBruce GilUpdatedOctober 2, 2024
CVS will cut almost 3,000 jobs as it plans AI investments — and considers breaking upByBruce GilUpdatedOctober 1, 2024
'I will cripple you,’ dockworkers union chief said of economy before massive port strikeByBruce GilPublishedOctober 1, 2024
New weight loss drugs could be developed much faster if Roche gets its wayByBruce GilPublishedSeptember 30, 2024
Costco, Hims, Noom, and more: 6 companies that started hawking weight loss products this yearByBruce GilPublishedSeptember 30, 2024
WeightWatchers is struggling in the weight loss drug era — and now the CEO is outByBruce GilPublishedSeptember 27, 2024
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatmentByBruce GilPublishedSeptember 27, 2024
